Smart Portfolios LLC’s ARK Genomic Revolution ETF ARKG Stock Holding History

Smart Portfolios LLC’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.46M	Buy	34,428 +862	+3%	+$30.1K	2.95%	9
2022 Q1	$1.54M	Buy	33,566 +5,678	+20%	+$271K	2.44%	13
2021 Q4	$1.71M	Buy	27,888 +5,530	+25%	+$382K	1.3%	24
2021 Q3	$1.67M	Buy	22,358 +1,868	+9%	+$157K	1.33%	21
2021 Q2	$1.9M	Buy	20,490 +14,012	+216%	+$1.19M	1.46%	20
2021 Q1	$575K	Buy	+6,478	New	+$643K	0.49%	27

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Smart Portfolios LLC's ARKG Position: Q2 2022 in Review

Smart Portfolios LLC increased its ARK Genomic Revolution ETF (ARKG) stake by 2.6% in Q2 2022, buying an estimated $30.1K and bringing the position to 34,428 shares worth $1.46M. The position accounts for 2.95% of the portfolio, ranked #9.

Smart Portfolios LLC first reported a position in ARKG in Q1 2021 and has held it in 6 quarters since. The position peaked at $1.9M in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Smart Portfolios LLC held 34,428 shares of ARK Genomic Revolution ETF worth $1.46M as of Q2 2022.
Smart Portfolios LLC bought 862 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $30.1K.
ARK Genomic Revolution ETF made up 2.95% of Smart Portfolios LLC's portfolio in Q2 2022, its #9 holding.
Smart Portfolios LLC first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 6 quarters since.
Smart Portfolios LLC's ARK Genomic Revolution ETF position peaked at $1.9M in Q2 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Smart Portfolios LLC's 13F filing for Q2 2022, filed 16 Aug 2022.